[1]
|
Fattovich, G., Stroffolini, T., Zagni, I. and Donato, F. (2004) Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk Factors. Gastroenterology, 127, S35-S50. https://doi.org/10.1053/j.gastro.2004.09.014
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[3]
|
Forner, A., Reig, M. and Bruix, J. (2018) Hepatocellular Carcinoma. The Lancet, 391, 1301-1314.
https://doi.org/10.1016/S0140-6736(18)30010-2
|
[4]
|
Yang, C., Zhang, H., Zhang, L., Zhu, A.X., Bernards, R., Qin, W., et al. (2023) Evolving Therapeutic Landscape of Advanced Hepatocellular Carcinoma. Nature Reviews Gastro-enterology & Hepatology, 20, 203-222.
https://doi.org/10.1038/s41575-022-00704-9
|
[5]
|
Nault, J.C. and Villanueva, A. (2021) Biomarkers for Hepatobil-iary Cancers. Hepatology, 73, 115-127.
https://doi.org/10.1002/hep.31175
|
[6]
|
Chidambaranathan-Reghupaty, S., Fisher, P.B. and Sarkar, D. (2021) Hepatocellular Carcinoma (HCC): Epidemiology, Etiology and Molecular Classification. Advances in Cancer Research, 149, 1-61.
https://doi.org/10.1016/bs.acr.2020.10.001
|
[7]
|
Schumacher, T.N. and Thommen, D.S. (2022) Tertiary Lymphoid Structures in Cancer. Science, 375, eabf9419.
https://doi.org/10.1126/science.abf9419
|
[8]
|
Feng, H., Yang, F., Qiao, L., Zhou, K., Wang, J., Zhang, J., et al. (2021) Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients with Lung Adenocarcino-ma. Frontiers in Oncology, 11, Article ID: 693234.
https://doi.org/10.3389/fonc.2021.693234
|
[9]
|
Zhang, C., Wang, X.Y., Zuo, J.L., Wang, X.F., Feng, X.W., Zhang, B., et al. (2023) Localization and Density of Tertiary Lymphoid Structures Associate with Molecular Subtype and Clini-cal Outcome in Colorectal Cancer Liver Metastases. The Journal for ImmunoTherapy of Cancer, 11, e006425. https://doi.org/10.1136/jitc-2022-006425
|
[10]
|
Calderaro, J., Petitprez, F., Becht, E., Laurent, A., Hirsch, T.Z., Rousseau, B., et al. (2019) Intra-Tumoral Tertiary Lymphoid Structures Are Associated with a Low Risk of Early Re-currence of Hepatocellular Carcinoma. Journal of Hepatology, 70, 58-65. https://doi.org/10.1016/j.jhep.2018.09.003
|
[11]
|
Li, J., Nie, Y., Jia, W., Wu, W., Song, W. and Li, Y. (2022) Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism. Cancers (Basel), 14, Article No. 5157. https://doi.org/10.3390/cancers14205157
|
[12]
|
Zhang, T., Lei, X., Jia, W., Li, J., Nie, Y., Mao, Z., et al. (2023) Peritumor Tertiary Lymphoid Structures Are Associated with Infiltrating Neutrophils and Inferior Prognosis in Hepato-cellular Carcinoma. Cancer Medicine, 12, 3068-3078. https://doi.org/10.1002/cam4.5227
|
[13]
|
Chi, Y., Wang, D., Wang, J., Yu, W. and Yang, J. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8, Article No. 1015. https://doi.org/10.3390/cells8091015
|
[14]
|
Chen, Y.G., Satpathy, A.T. and Chang, H.Y. (2017) Gene Regu-lation in the Immune System by Long Noncoding RNAs. Nature Immunology, 18, 962-972. https://doi.org/10.1038/ni.3771
|
[15]
|
Han, Q., Wang, M., Dong, X., Wei, F., Luo, Y. and Sun, X. (2022) Non-Coding RNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Ther-apeutic Potential. Frontiers in Immunology, 13, Article ID: 985815. https://doi.org/10.3389/fimmu.2022.985815
|
[16]
|
Xu, W., Ma, C., Liu, W., Anwaier, A., Tian, X., Shi, G., et al. (2022) Prognostic Value, DNA Variation and Immunologic Features of a Tertiary Lymphoid Structure-Related Chemo-kine Signature in Clear Cell Renal Cell Carcinoma. Cancer Immunology, Immunotherapy, 71, 1923-1935. https://doi.org/10.1007/s00262-021-03123-y
|
[17]
|
Zhang, Z. and Kattan, M.W. (2017) Drawing Nomograms with R: Applications to Categorical Outcome and Survival Data. Annals of Translational Medicine, 5, Article No. 211. https://doi.org/10.21037/atm.2017.04.01
|
[18]
|
Yu, G., Wang, L.G., Han, Y. and He, Q.Y. (2012) clusterProfiler: An R Package for Comparing Biological Themes among Gene Clusters. Omics, 16, 284-287. https://doi.org/10.1089/omi.2011.0118
|
[19]
|
Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., et al. (2015) Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Research, 43, e47.
https://doi.org/10.1093/nar/gkv007
|
[20]
|
Becht, E., Giraldo, N.A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., et al. (2016) Estimating the Population Abundance of Tissue-Infiltrating Immune and Stromal Cell Populations Using Gene Expression. Genome Biology, 17, Article No. 218. https://doi.org/10.1186/s13059-016-1070-5
|
[21]
|
Chen, B., Khodadoust, M.S., Liu, C.L., Newman, A.M. and Alizadeh, A.A. (2018) Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods in Molecular Biology, 1711, 243-259.
https://doi.org/10.1007/978-1-4939-7493-1_12
|
[22]
|
Fu, J., Li, K., Zhang, W., Wan, C., Zhang, J., Jiang, P., et al. (2020) Large-Scale Public Data Reuse to Model Immunotherapy Response and Resistance. Genome Medicine, 12, Article No. 21. https://doi.org/10.1186/s13073-020-0721-z
|
[23]
|
Maeser, D., Gruener, R.F. and Huang, R.S. (2021) onco-Predict: An R Package for Predicting in Vivo or Cancer Patient Drug Response and Biomarkers from Cell Line Screening Data. Briefings in Bioinformatics, 22, bbab260.
https://doi.org/10.1093/bib/bbab260
|
[24]
|
Geeleher, P., Cox, N. and Huang, R.S. (2014) pRRophetic: An R Pack-age for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels. PLOS ONE, 9, e107468. https://doi.org/10.1371/journal.pone.0107468
|
[25]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[26]
|
Jemal, A., Ward, E.M., Johnson, C.J., Cronin, K.A., Ma, J., Ryerson, B., et al. (2017) Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. JNCI: Journal of the National Cancer Institute, 109, djx030.
https://doi.org/10.1093/jnci/djx030
|
[27]
|
Llovet, J.M., Castet, F., Heikenwalder, M., Maini, M.K., Mazzaferro, V., Pinato, D.J., et al. (2022) Immunotherapies for Hepatocellular Carcinoma. Nature Reviews Clinical Oncology, 19, 151-172.
https://doi.org/10.1038/s41571-021-00573-2
|
[28]
|
Zhang, J.S., Wang, Z.H., Guo, X.G., Zhang, J. and Ni, J.S. (2022) A Nomogram for Predicting the Risk of Postoperative Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma in Patients with High Preoperative Serum Glutamyl Transpeptidase. Journal of Gastrointestinal Oncology, 13, 298-310. https://doi.org/10.21037/jgo-21-450
|
[29]
|
Guo, Y., Qu, Z., Li, D., Bai, F., Xing, J., Ding, Q., et al. (2021) Identification of a Prognostic Ferroptosis-Related lncRNA Signature in the Tumor Microenvironment of Lung Adenocar-cinoma. Cell Death Discovery, 7, Article No. 190. https://doi.org/10.1038/s41420-021-00576-z
|
[30]
|
Quail, D.F. and Joyce, J.A. (2013) Microenvironmental Regulation of Tumor Progression and Metastasis. Nature Medicine, 19, 1423-1437. https://doi.org/10.1038/nm.3394
|
[31]
|
Gupta, Y.H., Khanom, A. and Acton, S.E. (2022) Control of Dendritic Cell Function within the Tumour Microenvironment. Frontiers in Immunology, 13, Article ID: 733800. https://doi.org/10.3389/fimmu.2022.733800
|
[32]
|
Tokunaga, R., Naseem, M., Lo, J.H., Battaglin, F., Soni, S., Puc-cini, A., et al. (2019) B Cell and B Cell-Related Pathways for Novel Cancer Treatments. Cancer Treatment Reviews, 73, 10-19. https://doi.org/10.1016/j.ctrv.2018.12.001
|
[33]
|
Finkin, S., Yuan, D., Stein, I., Taniguchi, K., Weber, A., Unger, K., et al. (2015) Ectopic Lymphoid Structures Function as Microniches for Tumor Progenitor Cells in Hepatocel-lular Carcinoma. Nature Immunology, 16, 1235-1244.
https://doi.org/10.1038/ni.3290
|
[34]
|
Huang, Z., Zhou, J.K., Peng, Y., He, W. and Huang, C. (2020) The Role of Long Noncoding RNAs in Hepatocellular Carcinoma. Molecular Cancer, 19, Article No. 77. https://doi.org/10.1186/s12943-020-01188-4
|
[35]
|
Negrini, S., Gorgoulis, V.G. and Halazonetis, T.D. (2010) Ge-nomic Instability—An Evolving Hallmark of Cancer. Nature Reviews Molecular Cell Biology, 11, 220-228. https://doi.org/10.1038/nrm2858
|
[36]
|
Lai, P.B.S., Chi, T.Y. and Chen, G.G. (2007) Different Levels of p53 In-duced Either Apoptosis or Cell Cycle Arrest in a Doxycycline-Regulated Hepatocellular Carcinoma Cell Line in Vitro. Apoptosis, 12, 387-393.
https://doi.org/10.1007/s10495-006-0571-1
|
[37]
|
Liu, J., Ma, Q., Zhang, M., Wang, X., Zhang, D., Li, W., et al. (2012) Alterations of TP53 Are Associated with a Poor Outcome for Patients with Hepatocellular Carcinoma: Evidence from a Systematic Review and Meta-Analysis. European Journal of Cancer, 48, 2328-2338. https://doi.org/10.1016/j.ejca.2012.03.001
|
[38]
|
Huo, J., Wu, L. and Zang, Y. (2021) Development and Validation of a CTNNB1-Associated Metabolic Prognostic Model for Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine, 25, 1151-1165.
https://doi.org/10.1111/jcmm.16181
|
[39]
|
Akman, M., Belisario, D.C., Salaroglio, I.C., Kopecka, J., Donadelli, M., De Smaele, E., et al. (2021) Hypoxia, Endoplasmic Reticulum Stress and Chemoresistance: Dangerous Liaisons. Journal of Experimental & Clinical Cancer Research, 40, Article No. 28. https://doi.org/10.1186/s13046-020-01824-3
|